From: Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
Screening and diagnostics | Â | 95% CI |
---|---|---|
 MRI screening* | 1.000 | - |
 Mammography | 1.000 | - |
 Diagnostic workup | 0.987 | 0.761-1.00 |
Treatment†| ||
 In situ | 0.965 | 0.463-1.00 |
 Localized | 0.860 | 0.330-1.00 |
 Regional | 0.675 | 0.315-0.929 |
 Distant | 0.380 | 0.211-0.564 |
 Progression (end of life) | 0.380 | 0.211-0.564 |
 Remission | 0.965 | 0.463-1.00 |
Dead | 0.000 | - |
Well | 1.000 | - |